INNATE PHARMA

Identification
Symbol
IPH
ISIN code
FR0010331421
Trading location
Paris
ICB
Biotechnology
Website address
http://www.innate-pharma.com/
Issuer website
http://www.innate-pharma.com/
Operation
IPO date
IPO type

<p>
Global Placement and Open Price Offer</p>

IPO price
4.50 euros
IPO type
Initial Public offering
Catégorie
IPO
Operation procedure

<p>
Open Price Offer procedure Subscription open for mainly Retail investors. Number of shares: a maximum of 554,217 shares after exercise of extension option and before exercise of Green Shoe. Extension option: According to the importance of demand, Innate Pharma and in accordance with the bookrunners-leadmanagers, Bryan, Garnier and Co Limited and SOCIETE GENERALE Corporate and Investment Banking could decide to increase the number of shares offered to the public up to 722,891 additional new shares (i.e a maximum of 15% of the number of shares initially offered to the public).</p>

Operation description
Operation calendar

<p>
- Period of the OPO : From October 19th, 2006 to October 30th, 2006 (17:00) - First quotation: October 31st, 2006 - Beginning of trading: November 1st, 2006 - From 1st to 3rd November 2006 inclusive: trading of new and existing shares on a single quotation line &quot;Innate Pharma Promesses&quot; under the ISIN code FR0010331421 and mnemonic IPH. - From 4th November 2006: the shares will be quoted under the title &quot;Innate Pharma&quot;, ISIN code FR0010331421 (unchanged) and mnemonic IPH (unchanged).</p>

Price range
4.15 euros - 4.80 euros
Broker to issue

<p>
SOCIETE GENERALE Corporate and Investment Banking<br />
BRYAN, GARNIER and Co Limited</p>